Novel algorithm enables detailed analysis of copolymers
Peer-Reviewed Publication
Updates every hour. Last Updated: 22-Aug-2025 18:11 ET (22-Aug-2025 22:11 GMT/UTC)
Researchers at ETH have used nuclear magnetic resonance to find out what other atoms are bound to the platinum atoms in a single-atom catalyst and where they are spatially located.
The precise knowledge of the atomic environments can help produce single-atom catalysts that are more uniform, and thus more effective.
This also enables very efficient and resource-saving reaction accelerators for sustainable chemicals.
Bimodal pressure sensors capable of simultaneously detecting static and dynamic forces are essential to medical detection and bio-robotics. However, conventional pressure sensors typically integrate multiple operating mechanisms to achieve bimodal detection, leading to complex device architectures and challenges in signal decoupling. In this work, we address these limitations by leveraging the unique piezotronic effect of Y-ion-doped ZnO to develop a bimodal piezotronic sensor (BPS) with a simplified structure and enhanced sensitivity. Through a combination of finite element simulations and experimental validation, we demonstrate that the BPS can effectively monitor both dynamic and static forces, achieving an on/off ratio of 1029, a gauge factor of 23,439 and a static force response duration of up to 600 s, significantly outperforming the performance of conventional piezoelectric sensors. As a proof-of-concept, the BPS demonstrates the continuous monitoring of Achilles tendon behavior under mixed dynamic and static loading conditions. Aided by deep learning algorithms, the system achieves 96% accuracy in identifying Achilles tendon movement patterns, thus enabling warnings for dangerous movements. This work provides a viable strategy for bimodal force monitoring, highlighting its potential in wearable electronics.
A comprehensive review reveals that blocking natural killer cell checkpoints and employing precision strategies like gene editing and engineered cell therapies could significantly enhance cancer immunotherapy outcomes for solid tumors and blood cancers.